Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Alzheimer disease: from inherited to sporadic AD-crossing the biomarker bridge.

Literature DB >> 23007701

Alzheimer disease: from inherited to sporadic AD-crossing the biomarker bridge.

Abstract

Whether dominantly inherited variants of Alzheimer disease (AD) and 'sporadic' forms exhibit similar pathophysiological and biomarker signatures remains unresolved. A landmark study has proposed a biomarker progression model of dominantly inherited AD, but a complex systems biology and physiology approach is required to translate these findings to sporadic disease.

Entities: Disease

Mesh：

Substances：

Year: 2012 PMID： 23007701 DOI： 10.1038/nrneurol.2012.202

Source DB: PubMed Journal: Nat Rev Neurol ISSN： 1759-4758 Impact factor: 42.937

8 in total

1. US government sets out Alzheimer's plan.

Authors: Meredith Wadman
Journal: Nature Date: 2012-05-22 Impact factor: 49.962

Review 2. Development of biomarkers to chart all Alzheimer's disease stages: the royal road to cutting the therapeutic Gordian Knot.

Authors: Harald Hampel; Simone Lista; Zaven S Khachaturian
Journal: Alzheimers Dement Date: 2012-07 Impact factor: 21.566

Review 3. Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives.

Authors: Harald Hampel; Richard Frank; Karl Broich; Stefan J Teipel; Russell G Katz; John Hardy; Karl Herholz; Arun L W Bokde; Frank Jessen; Yvonne C Hoessler; Wendy R Sanhai; Henrik Zetterberg; Janet Woodcock; Kaj Blennow
Journal: Nat Rev Drug Discov Date: 2010-07 Impact factor: 84.694

4. The role of genetics for biomarker development in neurodegeneration.

Authors: Lars Bertram; Harald Hampel
Journal: Prog Neurobiol Date: 2011-10-12 Impact factor: 11.685

Review 5. Advances and perspectives from genetic research: development of biological markers in Alzheimer's disease.

Authors: Thomas Zetzsche; Dan Rujescu; John Hardy; Harald Hampel
Journal: Expert Rev Mol Diagn Date: 2010-07 Impact factor: 5.225

Review 6. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.

Authors: Kaj Blennow; Harald Hampel; Michael Weiner; Henrik Zetterberg
Journal: Nat Rev Neurol Date: 2010-02-16 Impact factor: 42.937

7. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

Authors: Clifford R Jack; David S Knopman; William J Jagust; Leslie M Shaw; Paul S Aisen; Michael W Weiner; Ronald C Petersen; John Q Trojanowski
Journal: Lancet Neurol Date: 2010-01 Impact factor: 44.182

8. Clinical and biomarker changes in dominantly inherited Alzheimer's disease.

Authors: Randall J Bateman; Chengjie Xiong; Tammie L S Benzinger; Anne M Fagan; Alison Goate; Nick C Fox; Daniel S Marcus; Nigel J Cairns; Xianyun Xie; Tyler M Blazey; David M Holtzman; Anna Santacruz; Virginia Buckles; Angela Oliver; Krista Moulder; Paul S Aisen; Bernardino Ghetti; William E Klunk; Eric McDade; Ralph N Martins; Colin L Masters; Richard Mayeux; John M Ringman; Martin N Rossor; Peter R Schofield; Reisa A Sperling; Stephen Salloway; John C Morris
Journal: N Engl J Med Date: 2012-07-11 Impact factor: 91.245

8 in total

15 in total

Review 1. DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences—part 2: bipolar disorders, schizophrenia spectrum disorders, anxiety disorders, obsessive-compulsive disorders, trauma- and stressor-related disorders, personality disorders, substance-related and addictive disorders, neurocognitive disorders.

Authors: Hans-Jürgen Möller; Borwin Bandelow; Michael Bauer; Harald Hampel; Sabine C Herpertz; Michael Soyka; Utako B Barnikol; Simone Lista; Emanuel Severus; Wolfgang Maier
Journal: Eur Arch Psychiatry Clin Neurosci Date: 2014-08-26 Impact factor: 5.270

2. Use of biomarkers and imaging to assess pathophysiology, mechanisms of action and target engagement.

Authors: H Hampel; S Lista
Journal: J Nutr Health Aging Date: 2013-01 Impact factor: 4.075

3. PRECISION MEDICINE - The Golden Gate for Detection, Treatment and Prevention of Alzheimer's Disease.

Authors: H Hampel; S E O'Bryant; J I Castrillo; C Ritchie; K Rojkova; K Broich; N Benda; R Nisticò; R A Frank; B Dubois; V Escott-Price; S Lista
Journal: J Prev Alzheimers Dis Date: 2016-09-06

Review 4. Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology.

Authors: Harald Hampel; Nicola Toschi; Claudio Babiloni; Filippo Baldacci; Keith L Black; Arun L W Bokde; René S Bun; Francesco Cacciola; Enrica Cavedo; Patrizia A Chiesa; Olivier Colliot; Cristina-Maria Coman; Bruno Dubois; Andrea Duggento; Stanley Durrleman; Maria-Teresa Ferretti; Nathalie George; Remy Genthon; Marie-Odile Habert; Karl Herholz; Yosef Koronyo; Maya Koronyo-Hamaoui; Foudil Lamari; Todd Langevin; Stéphane Lehéricy; Jean Lorenceau; Christian Neri; Robert Nisticò; Francis Nyasse-Messene; Craig Ritchie; Simone Rossi; Emiliano Santarnecchi; Olaf Sporns; Steven R Verdooner; Andrea Vergallo; Nicolas Villain; Erfan Younesi; Francesco Garaci; Simone Lista
Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472

5. Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer's Disease Dementia in Individuals With Mild Cognitive Impairment.

Authors: Yong Shen; Haibo Wang; Qiying Sun; Hailan Yao; Andrew P Keegan; Mike Mullan; Jeffrey Wilson; Simone Lista; Thomas Leyhe; Christoph Laske; Dan Rujescu; Allan Levey; Anders Wallin; Kaj Blennow; Rena Li; Harald Hampel
Journal: Biol Psychiatry Date: 2017-03-27 Impact factor: 13.382